Emergent BioSolutions
EBS
#6932
Rank
โ‚น53.63 B
Marketcap
โ‚น1,005
Share price
1.05%
Change (1 day)
62.26%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น53.63 Billion

As of February 2026 Emergent BioSolutions has a market cap of โ‚น53.63 Billion. This makes Emergent BioSolutions the world's 6932th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น53.63 B-9.91%
2025โ‚น59.53 B54.86%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On Feb 23rd, 2026 the market cap of Emergent BioSolutions was reported to be:

โ‚น52.20 Billion
by Nasdaq info icon info icon
โ‚น53.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.094 T 26,179.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น28.304 T 52,675.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.850 T 20,131.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚น1.01 B-98.10%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น44.82 B-16.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น149.74 B 179.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.587 T 6,588.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel